CIK: 1553595 - Address: C/O Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL 60607
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/17/23 17:58
11/17/23
XERSXeris Biopharma Holdings, Inc.HealthDrugPharmaceutical PreparationsShannon John Patrick JrILOSee RemaP501.6403121,409D
11/12/21 17:12
11/11/21
XERSXeris Biopharma Holdings, Inc.DEHealthDrugPharmaceutical PreparationsShannon John Patrick JrILOSee RemaP.m2102.10010038364D
5/14/20 16:30
5/13/20
XERSXeris Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShannon John Patrick JrILOSee RemaP783.5502223117D
5/11/20 18:17
5/8/20
XERSXeris Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShannon John Patrick JrILOSee RemaP253.2008995D
2/18/20 17:02
2/14/20
XERSXeris Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsShannon John Patrick JrILOSee RemaP504.1501211423D
8/13/14 17:13
8/12/14
DRTXDurata Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsShannon John Patrick JrILOChief CoP4113.72033811D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact